Table 1.
Baseline characteristics of studied population according to gender
| Total n = 650 | Men n = 313 | Women n = 337 | p | |
|---|---|---|---|---|
| Age1 (years) |
48.4 (SD = 12.5) |
48.9 (SD = 12.5) |
48.0 (SD = 12.5) |
0.341 |
| Waist C1 (cm) |
92.3 (SD = 13.6) |
97.7 (SD = 11.6) |
87.1 (SD = 13.3) |
<0.001 |
| BMI1 (kg/m2) |
26.4(SD = 4.5) |
27.1 (SD = 4.1) |
25.7 (SD = 4.7) |
<0.001 |
| Fasting glucose1 (mg/dl) |
93.6 (SD = 14.6) |
95.5 (SD = 14.6) |
91.9 (SD = 14.3) |
0.002 |
| Total cholesterol1 (mg/dl) |
204.9 (SD = 39.6) |
201.8 (SD = 41.2) |
207.8 (SD = 37.8) |
0.051 |
| HDL-cholesterol1 (mg/dl) |
58.7 (SD = 14.7) |
55.4 (SD = 13.4) |
61.8 (SD = 15.3) |
<0.001 |
| Triglyceride1 (mg/dl) |
123.0 (SD = 83.4) |
138.7 (SD = 102.6) |
108.3 (SD = 56.5) |
<0.001 |
| SBP1 (mm Hg) |
127.2 (SD = 16.2) |
130.5 (SD = 16.1) |
124.2 (SD = 15.7) |
<0.001 |
| DBP1 (mm Hg) |
77.3 (SD = 10.5) |
79.5 (SD = 10.2) |
75.2 (SD = 10.3) |
<0.001 |
| CVR1 (Score) |
1.5 (SD = 1.9) |
2.4 (SD = 2.1) |
0.8 (SD = 1.1) |
<0.001 |
| CVR1 (Regicor) |
3.4 (SD = 2.3) |
3.9 (SD = 2.6) |
2.9 (SD = 1.9) |
<0.001 |
| AC drugs2 |
30.0 (26.5-33.5) |
33.5 (28.3-38.7) |
26.7 (22.0-31.4) |
0.060 |
| AH drugs2 |
32.3 (28.7-35.9) |
40.3 (34.9-45.7) |
24.9 (20.3-29.5) |
<0.001 |
| Smoking habit2 |
30.0 (26.5-33.5) |
34.8 (29.5-40.1) |
25.5 (20.8-30.2) |
0.010 |
| Physical inactivity2 | 58.5 (54.7-62.3) | 52.7 (47.2-58.2) | 63.8 (58.7-68.9) | 0.005 |
p ≤ 0.05 is considered to be statistically significant.
1Data are expressed as means (Standard Deviation).
2Data are expressed as percentages (95% confidence interval).
Waist C waist circumference; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; CVR cardiovascular risk; AC Drugs pharmacological treatment of hypercholesterolemia or hypertriglyceridemia; AH Drugs pharmacological treatment of hypertension.